• Ebastine Film Coated Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Rapid-Dissolution Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the piperidine derivative API.

    Active IngredientStrengthPrimary Clinical Function
    Ebastine USP/Ph.Eur.10 mgThe Standard Allergy Anchor: The definitive once-daily unit utilized for the baseline control of Seasonal and Perennial Allergic Rhinitis (Hay Fever).
    Ebastine USP/Ph.Eur.20 mgThe Dermatology Macrodose: High-efficacy therapeutic payload utilized strictly for severe, refractory Chronic Idiopathic Urticaria (hives) or intensely severe allergic rhinitis.
    ExcipientsMicrocrystalline Cellulose / Lactose Monohydrate / Croscarmellose Sodium / Magnesium Stearate / Premium Polymeric FilmDiluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered utilizing elite rapid-burst disintegrants to ensure the tablet dissolves instantly in gastric fluid, expediting the hepatic conversion to Carebastine for the fastest possible onset of clinical relief)

    *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, 30-day chronic allergy and dermatology dispensing regimens).

  • Everolimus Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Antioxidant-Stabilized Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the highly oxidative, potent API.

    Active IngredientStrengthPrimary Clinical Function
    Everolimus USP/Ph.Eur.0.25 mg / 0.5 mg / 0.75 mgGlobal Transplant Standard: Ultra-micro doses utilized for strict, lifelong immunosuppression following renal or hepatic allografts. Requires extreme content uniformity to maintain the narrow therapeutic blood trough levels (3 to 8 ng/mL).
    Everolimus USP/Ph.Eur.5 mg / 10 mgGlobal Oncology Standard: Massive-dose antineoplastic payload utilized for the aggressive suppression of Renal Cell Carcinoma, Neuroendocrine Tumors (NETs), and HR+/HER2- Breast Cancer.
    ExcipientsButylated Hydroxytoluene (BHT) / Hypromellose / Lactose Anhydrous / Crospovidone / Magnesium StearateAntioxidant / Binder / Diluent / Superdisintegrant / Lubricant (Engineered specifically utilizing BHT (Butylated Hydroxytoluene) to prevent the rapid oxidative degradation of the Everolimus molecule, guaranteeing maximum clinical shelf-life and potency across harsh climates)

    *Pack Sizes: 10×10 Alu-Alu Blisters (Transplant) or 3×10 Alu-Alu Blisters (Oncology – 30 Day Supply).